Benefits to Patients
Witnessing Lexicon’s drug candidates provide benefits in patients is gratifying and validates our strategy.
-Brian Zambrowicz, Chief Scientific Officer
Commitment to Excellence
Lexicon's commitment to utilizing the best science, and a strong team-based culture, is fundamental to our strategy of discovering first-in-class and best-in-class drugs that will improve the lives of patients.
-Alan Wilson, VP, DMPK
Unique Pipeline of Drug Candidates
I believe Lexicon’s unique pipeline of first-in-class drug candidates will provide substantial value to both partners and patients.
-Jeff Wade, EVP, Corporate Development & CFO
Through the collaborative spirit that is pervasive at Lexicon, a CPA feels as intrinsically important as a chemist to the success of the company.
-Jim Tessmer, VP, Finance & Accounting